Validity and reliability of the CERAD-Col neuropsychological battery;Validez y fiabilidad de la batería neuropsicológica CERAD-Col

Revista de Neurologia

Volumn 45, Issue 11, 2007, Pages 655-660

  Aguirre Acevedo, Daniel Camilo ^a   Gomez R D ^a   Moreno, S ^a   Henao Arboleda, E ^a   Motta, M ^a   Munoz C ^a   Arana, A ^a   Pineda, D A ^a,b   Lopera, F ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b UNIVERSIDAD DE SAN BUENAVENTURA   (Colombia)

Author keywords

Alzheimer's disease; CERAD; Dementia; Neuropsychological; Reliability; Validity

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CERAD COL NEUROPSYCHOLOGICAL TEST; COGNITIVE DEFECT; COLOMBIA; CONSTRUCT VALIDITY; CONTROLLED STUDY; FACTORIAL ANALYSIS; FEMALE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; REPRODUCIBILITY; STATISTICAL SIGNIFICANCE;

EID: 37349087171     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4511.2007086     Document Type: Article

References (50)

1. Pradilla AG, Vesga AB, Leon-Sarmiento FE. National neuroepidemiological study in Colombia (EPINEURO). Rev Panam Salud Publica 2003; 14: 104-11.
2. Morris JC, Heyman A, Mohs RC, Hughes JP, Van Belle G, Fillenbaum G, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989; 39: 1159-65.
3. Welsh KA, Butters N, Mohs RC, Beekly D, Edland S, Fillenbaum G, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology 1994; 44: 609-14.
4. Homma A, Niina R, Ishii T, Hirata N, Hasegawa K. Reliability and validity of the Japanese version of the GBS scale. Nippon Ronen Igakkai Zasshi 1989; 26: 617-23.
5. Krzyminska E, Rossa G, Krzyminski S. The Global Deterioration Scale (GDS) and Functional Assessment Staging (FAST) in the diagnosis of Alzheimer type dementia. Psychiatr Pol 1993; 27: 129-38.
6. Reisberg B. Functional assessment staging (FAST). Psychopharmacol Bull 1988; 24: 653-9.
7. Sclan SG, Reisberg B. Functional assessment staging (FAST) in Alzheimer's disease: reliability, validity, and ordinality. Int Psychogeriatr 1992; 4 (Suppl 1): S55-69.
8. Auer S, Reisberg B. The GDS/FAST staging system. Int Psychogeriatr 1997; 9 (Suppl 1): S167-71.
9. Guruje O, Unverzargt FW, Osuntokun BO, Hendrie HC, Baiyewu O, Ogunniyi A, et al. The CERAD Neuropsychological Test Battery: norms from a Yoruba-speaking Nigerian sample. West Afr J Med 1995; 14: 29-33.
10. Fillenbaum GG, Heyman A, Huber MS, Ganguli M, Unverzagt FW. Performance of elderly African American and White community residents on the CERAD Neuropsychological Battery. J Int Neuropsychol Soc 2001; 7: 502-9.
11. Collie A, Shafiq-Antonacci R, Maruff P, Tyler P, Currie J. Norms and the effects of demographic variables on a neuropsychological battery for use in healthy ageing Australian populations. Aust N Z J Psychiatry 1999; 33: 568-75.
12. Berres M, Monsch AU, Bernasconi F, Thalmann B, Stahelin HB. Normal ranges of neuropsychological tests for the diagnosis of Alzheimer's disease. Stud Health Technol Inform 2000; 77: 195-9.
13. McCurry SM, Gibbons LE, Uomoto JM, Thompson ML, Graves AB, Edland SD, et al. Neuropsychological test performance in a cognitively intact sample of older Japanese American adults. Arch Clin Neuropsychol 2001; 16: 447-59.
14. Strauss ME, Fritsch T. Factor structure of the CERAD neuropsychological battery. J Int Neuropsychol Soc 2004; 10: 559-65.
15. Lee JH, Lee KU, Lee DY, Kim KW, Jhoo JH, et al. Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries. J Gerontol B Psychol Sci Soc Sci 2002; 57: 47-53.
16. Morris JC, Mohs RC, Rogers H, Fillenbaum G, Heyman A. Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol Bull 1988; 24: 641-52.
17. Stewart R, Richards M, Brayne C, Mann A. Cognitive function in UK community-dwelling African Caribbean elders: normative data for a test battery. Int J Geriatr Psychiatry 2001; 16: 518-27.
18. Unverzagt FW, Morgan OS, Thesiger CH, Eldemire DA, Luseko J, Pokuri S, et al. Clinical utility of CERAD neuropsychological battery in elderly Jamaicans. J Int Neuropsychol Soc 1999; 5: 255-9.
19. Bertolucci PH, Okamoto IH, Brucki SM, Siviero MO, Toniolo NJ, Ramos LR. Applicability of the CERAD neuropsychological battery to Brazilian elderly. Arq Neuropsiquiatr 2001; 59: 532-6.
20. Lee DY, Lee KU, Lee JH, Kim KW, Jhoo JH, Kim SY, et al. A normative study of the CERAD neuropsychological assessment battery in the Korean elderly. J Int Neuropsychol Soc 2004; 10: 72-81.
21. Maki N, Ikeda M, Hokoishi K, Nebu A, Komori K, Hirono N, et al. The validity of the MMSE and SMQ as screening tests for dementia in the elderly general population -a study of one rural community in Japan. Dement Geriatr Cogn Disord 2000; 11: 193-6.
22. Beeri MS, Schmeidler J, Sano M, Wang J, Lally R, Grossman H, et al. Age, gender, and education norms on the CERAD neuropsychological battery in the oldest old. Neurology 2006; 67: 1006-10.
23. Kunig G, Jager M, Stief V, Kaldune A, Urbaniok F, Endrass J. The impact of the CERAD-NP on diagnosis of cognitive deficiencies in late onset depression and Alzheimer's disease. Int J Geriatr Psychiatry 2006; 21: 911-6.
24. Jones SN, Ayers CR. Psychometric properties and factor structure of an expanded CERAD neuropsychological battery in an elderly VA sample. Arch Clin Neuropsychol 2006; 21: 359-65.
25. Fillenbaum GG, McCurry SM, Kuchibhatla M, Masaki KH, Borenstein AR, Foley DJ, et al. Performance on the CERAD neuropsychology battery of two samples of Japanese-American elders: norms for persons with and without dementia. J Int Neuropsychol Soc 2005; 11: 192-201.
26. Andel R, McCleary CA, Murdock GA, Fiske A, Wilcox RR, Gatz M. Performance on the CERAD Word List Memory task: a comparison of university-based and community-based groups. Int J Geriatr Psychiatry 2003; 18: 733-9.
27. Kaltreider LB, Cicerello AR, Lacritz LH, Honig LS, Rosenberg RN, Cullum MC. Comparison of the CERAD and CVLT list-learning tasks in Alzheimer's disease. Clin Neuropsychol 2000; 14: 269-74.
28. Spangenberg KB, Henderson S, Wagner MT. Validity of a recall and recognition condition to assess visual memory in the CERAD battery. Appl Neuropsychol 1997; 4: 154-9.
29. Morris JC, Edland S, Clark C, Galasko D, Koss E, Mohs R, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology 1993; 43: 2457-65.
30. Reisberg B, Ferris SH, De Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982; 139: 1136-9.
31. Reisberg B, Ferris SH, De Leon MJ, Crook T. Global Deterioration Scale (GDS). Psychopharmacol Bull 1988; 24: 661-3.
32. Trenkle DL, Shankle WR, Azen SP. Detecting cognitive impairment in primary care: performance assessment of three screening instruments. J Alzheimers Dis 2007; 11: 323-35.
33. Ravaglia G, Forti P, Maioli F, Servadei L, Martelli M, Brunetti N, et al. Screening for mild cognitive impairment in elderly ambulatory patients with cognitive complaints. Aging Clin Exp Res 2005; 17: 374-9.
34. Tirado V, Muñoz C, Aguirre-Acevedo DC, Pineda DA, Lopera F. Desempeño de portadores y no portadores de la mutación E280A para enfermedad de Alzheimer familiar en una prueba de denominación. Rev Neurol 2004; 39: 322-6.
35. Yeudall LT, Fromm D, Reddon JR, Stefanny WO. Normative data stratified by age and sex for 12 neuropsycholical test. J Clin Psychol 1986; 42: 918-46.
36. Strickland TL, Longobardi PG, Alperson BL, Andre K. Mini-Mental State and Cognistat performance in an older African American sample. Clin Neuropsychol 2005; 19: 87-98.
37. McCarten JR, Rottunda SJ, Kuskowski MA. Change in the mini-mental state exam in Alzheimer's disease over 2 years: the experience of a dementia clinic. J Alzheimers Dis 2004; 6: 11-5.
38. Ho SM, Fung WK, Chan CL, Watson M, Tsui YK. Psychometric properties of the Chinese version of the Mini-Mental Adjustment to Cancer (MINI-MAC) scale. Psychooncology 2003; 12: 547-56.
39. Imam I, Onifade A, Durodoye MO, Aje A, Sogaolu AO, Kehinde O, et al. Performance of normal Nigerian students on the mini-mental state examination. Niger J Med 2003; 12: 126-9.
40. Ala TA, Hughes LF, Kyrouac GA, Ghobrial MW, Elble RJ. The Mini-Mental State exam may help in the differentiation of dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry 2002; 17: 503-9.
41. Banos JH, Franklin LM. Factor structure of the Mini-Mental State Examination in adult psychiatric inpatients. Psychol Assess 2002; 14: 397-400.
42. Busse A, Sonntag A, Bischkopf J, Matschinger H, Angermeyer MC. Adaptation of dementia screening for vision-impaired older persons: administration of the Mini-Mental State Examination (MMSE). J Clin Epidemiol 2002; 55: 909-15.
43. Pasqualetti P, Moffa F, Chiovenda P, Carlesimo GA, Caltagirone C, Rossini PM. Mini-mental state examination and mental deterioration battery: analysis of the relationship and clinical implications. J Am Geriatr Soc 2002; 50: 1577-81.
44. Blesa R, Pujol M, Aguilar M, Santacruz P, Bertrán-Serra I, Hernández G, et al. Clinical validity of the 'Mini-Mental State' for Spanish speaking communities. Neuropsychologia 2001; 39: 1150-7.
45. Faustman WO, Moses JA, Jr., Csernansky JG. Limitations of the Mini-Mental State Examination in predicting neuropsychological functioning in a psychiatric sample. Acta Psychiatr Scand 1990; 81: 126-31.
46. Kawano M, Ichimiya A, Ogomori K, Kuwabara Y, Sasaki M, Yoshida T, et al. Relationship between both IQ and Mini-Mental State Examination and the regional cerebral glucose metabolism in clinically diagnosed Alzheimer's disease: a PET study. Dement Geriatr Cogn Disord 2001; 12: 171-6.
47. Koch HJ, Gurtler K, Szecsey A. Correlation of Mini-Mental State Examination (MMSE), Syndrom-Kurztest (SKT) and Clock Test (CT) scores in patients with cognitive impairment assessed by means of multiple regression and response surface analysis. Arch Gerontol Geriatr 2005; 40: 7-14.
48. Moretti R, Torre P, Antonello RM, Cazzato G. Ten-Point Clock test: a correlation analysis with mini-mental state and proverb interpretation score in Alzheimer's disease. Eur J Neurol 2000; 7: 746.
49. Richardson HE, Glass JN. A comparison of scoring protocols on the Clock Drawing Test in relation to ease of use, diagnostic group, and correlations with Mini-Mental State Examination. J Am Geriatr Soc 2002; 50: 169-73.
50. Wlodarczyk JH, Brodaty H, Hawthorne G. The relationship between quality of life, Mini-Mental State Examination, and the instrumental activities of daily living in patients with Alzheimer's disease. Arch Gerontol Geriatr 2004; 39: 25-33.